Ingold Heppner, Barbara <br/><br/>
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 2016 
 - 5747-5754 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-15-2338  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--metabolism<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Lapatinib<br/>Lymphocytes--drug effects<br/>Lymphocytes, Tumor-Infiltrating--drug effects<br/>Middle Aged<br/>Neoadjuvant Therapy--methods<br/>Prognosis<br/>Prospective Studies<br/>Quinazolines--therapeutic use<br/>Receptor, ErbB-2--metabolism<br/>Trastuzumab--therapeutic use<br/>Triple Negative Breast Neoplasms--metabolism